Books in Pharmaceutical sciences

441-450 of 465 results in All results

Robustness of Analytical Chemical Methods and Pharmaceutical Technological Products

1st Edition
Volume 19
December 11, 1996
M.M.W.B. Hendriks + 2 more
English
eBook
9 7 8 - 0 - 0 8 - 0 5 4 0 6 3 - 4

In analytical chemistry and pharmaceutical technology attention is increasingly focussed on improving the quality of methods and products. This book aims at fostering the awareness of the potential of existing mathematical and statistical methods to improve this quality. It provides procedures and ideas on how to make a product or a method less sensitive to small variations in influencing factors. Major issues covered are robustness and stability improvement and ruggedness testing. General strategies and a theoretical introduction to these methods are described, and thorough overviews of methods used in both application areas and descriptions of practical applications are given.Features of this book:• Gives a good overview of mathematical and statistical methods used in two application areas, i.e. pharmaceutical technology and analytical chemistry• Illustrates the different approaches available to attain robustness• Gives ideas on how to use methods in practical situations.The book is intended for those who develop and optimize, and are responsible for the overall quality of, analytical methods and pharmaceutical technological products and procedures.

Advances in Pharmacology

1st Edition
Volume 37
September 30, 1996
J. Thomas August + 3 more
English
Hardback
9 7 8 - 0 - 1 2 - 0 3 2 9 3 8 - 0
eBook
9 7 8 - 0 - 0 8 - 0 5 8 1 2 9 - 3

Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular bases of drug action, both applied and experimental.

Analytical Profiles of Drug Substances and Excipients

1st Edition
Volume 24
July 25, 1996
Harry G. Brittain
English
eBook
9 7 8 - 0 - 0 8 - 0 8 6 1 1 9 - 7

Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories. Edited by the Associate Director of Analytical Research and Development for the AmericanAssociation of Pharmaceutical Scientists, Analytical Profiles of Drug Substances and Excipients brings this information together into one source. The scope of the series has recently been expanded to include profiles of excipient materials.

Advances in Drug Research

1st Edition
Volume 28
July 2, 1996
Bernard Testa + 1 more
English
Hardback
9 7 8 - 0 - 1 2 - 0 1 3 3 2 8 - 4
eBook
9 7 8 - 0 - 0 8 - 0 5 2 6 7 1 - 3

This volume continues the trend for Advances in Drug Research of shorter, but more frequent volumes. In line with the tradition of the series, chapters on general themes are interspersed with chapters on specific drug classes and targets.

Advances in Antiviral Drug Design

1st Edition
Volume 2
April 23, 1996
E. De Clercq
English
eBook
9 7 8 - 0 - 0 8 - 0 5 2 6 0 3 - 4

The purpose of the series on Advances in Antiviral Drug Design is to regularly review the "state of the art" on emerging new developments in the antiviral drug research field, thereby spanning the conceptual design and chemical synthesis of new antiviral compounds, their structure-activity relationship, mechanism and target(s) of action, pharmacological behavior, antiviral activity spectrum, and therapeutic potential for clinical use. Volume 2 begins with a description of the antiviral potential of antisense oligonucleotides by J. Temsamani and S. Agrawal. According to the aims of the anitsense technology, these oligonucleotides should be targeted at specific viral antisense technology, these oligonucleotides should be targeted at specific viral mRNA sequences so that translation to the virus-specified proteins is blocked; this has been achieved for a number of oligomers, some of which are now in clinical trials for the treatment of HIV, HCMV, and human papilloma virus (HPV) infections. Then C.-S. Yuan, S. Liu, S.F. Wnuk, M.J. Robins and R.T. Borchardt assess the role of S-adenosylhornocysteine (AdoHcy) hydrolase as target for the design of antiviral agents with broad-spectrum antiviral activity. This is followed by an in-depth account on the design and synthesis of a number of first-, second- and third-generation AdoHcy hydrolase inhibitors and their mode of action at the enzyme level.V.E. Marquez provides a comprehensive description of the various carbocyclic (carba) nucleosides that have been synthesized and evaluated for antiviral activity. Although the number and diversity of the carba-nucleosides that have been found to be antivirally active (or inactive) is astonishingly high, there is no limit to further expansion of this fascinating class of molecules. For the various nucleoside analogues that have to be intracellularly phosphorylated to the 5'-triphosphate stage, to interact with their target enzyme (i.e., herpesviral DNA polymerase or retroviral revers transcriptase) the first phosphorylation step is often the rate-limiting step, and thus various strategies are envisaged by C. Perigoud, J.-L. Girardet, G. Gosselin and J.-L. Bach on how to bypass this initial phosphorylation and to deliver the nucleoside 5'-monophophate directly inside the cells.The HIV protease has been considered as a paradigm for rational drug design. The enzyme is among the best understood in terms of both structure and action, and because of its crucial role in the maturation of HIV, it has been vigorously pursued as a target for anti-HIV chemotherapy. In their comprehensive review of the multidisciplinary approach towards the development of HIV protease inhibitors A.G. Tomasselli, S. Thaisrivongs and R.L. Heinrikson highlight those protease inhibitors which have been brought forward to clinical trials.

Advances in Pharmacology

1st Edition
Volume 35
April 3, 1996
J. Thomas August + 3 more
English
Hardback
9 7 8 - 0 - 1 2 - 0 3 2 9 3 6 - 6
eBook
9 7 8 - 0 - 0 8 - 0 5 8 1 2 7 - 9

Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular bases of drug action, both applied and experimental.

Annual Reports on NMR Spectroscopy

1st Edition
Volume 32
March 5, 1996
Graham A. Webb
English
eBook
9 7 8 - 0 - 0 8 - 0 5 8 4 1 5 - 7

NMR is used in all areas of modern science, and its applications continue to grow. In 1995 we celebrate the 50th anniversary of the discovery of NMR Spectroscopy and almost 30 years since the appearance of the firstvolume of Annual Reports on NMR Spectroscopy. During these years, a large and diverse collection of topics have been covered, and the contents of Volume 32 are no exception. This volume consists of reviews covering four, clearly distinct areas of science.

QSAR and Drug Design: New Developments and Applications

1st Edition
Volume 23
November 20, 1995
H. Timmerman
T. Fujita
English
eBook
9 7 8 - 0 - 0 8 - 0 5 4 5 0 0 - 4

Based on topics presented at the Annual Japanese (Quantitative) Structure-Activity Relationship Symposium and the Biennial China-Japan Drug Design and Development conference, the topics in this volume cover almost every procedure and subdiscipline in the SAR discipline.They are categorized in three sections. Section one includes topics illustrating newer methodologies relating to ligand-receptor, molecular graphics and receptor modelling as well as the three-dimensional (Q)SAR examples with the active analogue approach and the comparative molecular field analysis. In section 2 the hydrophobicity parameters, log P (1-octanol/water) for compound series of medicinal-chemical interest are analysed physico-organic chemically. Section 3 contains the examples based on the traditional Hansch QSAR approach.A variety of methodologies and procedures are presented in this single volume, along with their methodological philosophies.

Peptides

1st Edition
October 19, 1995
Bernd Gutte
English
Hardback
9 7 8 - 0 - 1 2 - 3 1 0 9 2 0 - 0
eBook
9 7 8 - 0 - 0 8 - 0 5 3 8 5 9 - 4

In recent years, research has shown the importance of peptides in neuroscience, immunology, and cell biology. Active research programs worldwide are now engaged in developing peptide-based drugs and vaccines using modification of natural peptides and proteins, design of artificial peptides and peptide mimetics, and screening of peptide and phage libraries. In this comprehensive book, the authors discuss peptide synthesis and application within the context of their increasing importance to the pharmaceutical industry. Peptides: Synthesis, Structures, and Applications explores the broad growth of information in modern peptide synthetic methods and the structure-activity relationships of synthetic polypeptides.

Advances in Pharmaceutical Sciences

1st Edition
Volume 7
September 28, 1995
David Ganderton + 2 more
English
Hardback
9 7 8 - 0 - 1 2 - 0 3 2 3 0 7 - 4
eBook
9 7 8 - 0 - 0 8 - 0 5 2 6 8 4 - 3

The seventh volume of Advances in Pharmaceutical Sciences heralds a welcome continuation of this well-respected series. Acknowledged experts provide comprehensive statements of current research and development in selected fields of pharmaceutical technology. This book will be of great value to those working in academia and the pharmaceutical industry.